Vivos TherapeuticsVVOS
13F holders, Q1 2026 (March 31)24holders +5
6new positions
2sold out
$1.18avg. 13F price*
At the end of Q1 2026, 24 institutions reported holding Vivos Therapeutics Inc. (VVOS) in their 13F filings, up 5 from Q4 2025. 6 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($1.3M), Vanguard Capital Management LLC ($323K) and Geode Capital Management, LLC ($113K).
- Company
- Vivos Therapeutics Inc.
- CUSIP
- 92859E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.5M |
| Exits | 2 | $236K |
All 13F filers, Q4 2025 → Q1 2026: 1,287,403 shares bought and 123,135 shares sold, net +1,164,268 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Armistice Capital, LLC | 0.04% | New | 1,115,859 | $1.3M |
| Vanguard Capital Management LLC | 0.00% | — | 273,329 | $323K |
| Geode Capital Management, LLC | 0.00% | Add +69.7% | 95,543 | $113K |
| Commonwealth Equity Services, LLC | 0.00% | Add +4.9% | 42,500 | $50K |
| IHT Wealth Management, LLC | 0.00% | New | 41,061 | $48K |
| Centurion Wealth Management LLC | 0.01% | New | 35,684 | $42K |
| B. Riley Wealth Advisors, Inc. | 0.00% | Reduce -12.6% | 38,066 | $41K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 30,832 | $36K |
| BlackRock, Inc. | 0.00% | No change | 27,817 | $33K |
| XTX Topco Ltd | 0.00% | New | 25,117 | $30K |
| State Street Corp. | 0.00% | No change | 24,922 | $29K |
| Sequoia Financial Advisors, LLC | 0.00% | New | 24,000 | $28K |
| Acorn Wealth Advisors, LLC | 0.01% | No change | 14,776 | $17K |
| Northern Trust Corp. | 0.00% | No change | 12,511 | $15K |
| UBS Group AG | 0.00% | Reduce -12.9% | 11,046 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +149.2% | 7,388 | $9K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,143 | $1K |
| Signaturefd, LLC | 0.00% | No change | 547 | $645 |
| Blue Trust, Inc. | 0.00% | No change | 160 | $189 |
| Kozak & Associates, Inc. | 0.00% | No change | 49 | $60 |
| Morgan Stanley | 0.00% | No change | 7 | $8 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 3 | $4 |
| Citigroup Inc. | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is VVOS's weight in each manager's 13F, not the share of Vivos Therapeutics Inc. the manager owns.